News from amarantus bioscience, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Feb 04, 2014, 08:30 ET

Amarantus Announces Positive Phase 2a Data for Eltoprazine in Adult ADHD

 - 36 out of 47 adult subjects (77%) completed the double-blind placebo controlled, multiple dose, crossover study - Primary...

Feb 28, 2013, 08:00 ET

Amarantus BioScience to Present MANF Parkinson's Data at the 15th Annual American Society for Experimental NeuroTherapeutics

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases...

Feb 25, 2013, 10:32 ET

Amarantus BioScience and Banyan Biomarkers to Present Poster of MANF Data at The 3rd Annual Traumatic Brain Injury Conference

 Amarantus BioScience, Inc. (OTCQB:AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated...

Feb 08, 2013, 08:30 ET

Amarantus BioScience to Present at the 15th Annual BIO CEO & Investor Conference

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases...

Feb 06, 2013, 09:58 ET

OneMedPlace Research Releases Update to Research Report on Amarantus BioScience

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases...

Feb 04, 2013, 09:27 ET

Amarantus BioScience Reports Statistical Significance Achieved for MANF Striatal Reinnervation in Neurorestoration Animal Model of Parkinson's Disease

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases...

Jan 31, 2013, 06:00 ET

Amarantus BioScience Secures an Additional $1.4 Million in Financing Commitments

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases...

Jan 28, 2013, 09:29 ET

Amarantus BioScience Launches New Website

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases...

Jan 16, 2013, 08:36 ET

Amarantus BioScience Announces Publication of Independent Peer-Reviewed Data for Receptor and Secretion Pathways related to MANF

Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated...

Jan 10, 2013, 11:55 ET

Amarantus BioScience Announces Biotech Showcase 2013 Corporate Presentation is Available Online

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases...

Jan 09, 2013, 08:31 ET

Amarantus BioScience Announces Positive Efficacy Data for MANF in a Nigral Delivery Neurorestoration Animal Model of Parkinson's Disease

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases...

Jan 08, 2013, 09:51 ET

Amarantus Bioscience Neurorestoration Animal Data Presentation to be Webcast Live Today from OneMedForum 2013 at 4:40pm Eastern

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments for diseases associated with protein...

Dec 27, 2012, 08:43 ET

Amarantus BioScience to Present at Biotech Showcase 2013

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company developing treatments and diagnostics for diseases associated with...

Dec 26, 2012, 08:36 ET

Amarantus BioScience Acquires Neurodegenerative Diagnostic Intellectual Property Portfolio from Power3 Medical Products

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company developing treatments and diagnostics for diseases associated with...

Dec 20, 2012, 10:03 ET

Amarantus Bioscience to Present Parkinson's Neurorestoration Animal Data Results at OneMedForum

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments for diseases associated with protein...

Dec 14, 2012, 07:20 ET

Amarantus BioScience Licenses LymPro Alzheimer's Disease Diagnostic Blood Test

 Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments for diseases associated with protein...

Dec 11, 2012, 06:00 ET

Amarantus Bioscience Launches Online Corporate Communication Channels

Amarantus Bioscience, Inc. (OTCQB: AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and Traumatic...

Dec 06, 2012, 07:52 ET

Amarantus Bioscience to Present at OneMedForum 2013

 Amarantus Bioscience, Inc. (OTCQB: AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and...

Dec 04, 2012, 09:41 ET

Amarantus Appoints Super Bowl Champion Toi Cook to Board of Advisors to Advance TBI Program

 Amarantus Bioscience, Inc. (OTCQB: AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and...

Dec 03, 2012, 17:10 ET

Amarantus Completes Name Change and CUSIP Change

 Amarantus Bioscience, Inc. (OTCQB: AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson's disease and...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge